Weil Secures Landmark $407M Antitrust Jury Trial Victory For Regeneron in Competitor Dispute Regarding Biotech Innovation
May 16, 2025
May 16, 2025
NEW YORK, May 16 -- Weil, Gotshal and Manges, a law firm, issued the following news release:
* * *
Weil Secures Landmark $407M Antitrust Jury Trial Victory For Regeneron in Competitor Dispute Regarding Biotech Innovation
On May 15, 2025, a Weil trial and antitrust team won a significant plaintiff antitrust jury verdict for client Regeneron Pharmaceuticals, Inc. in Delaware federal court that is sure to reverberate throughout the pharmaceutical industry. Aft . . .
* * *
Weil Secures Landmark $407M Antitrust Jury Trial Victory For Regeneron in Competitor Dispute Regarding Biotech Innovation
On May 15, 2025, a Weil trial and antitrust team won a significant plaintiff antitrust jury verdict for client Regeneron Pharmaceuticals, Inc. in Delaware federal court that is sure to reverberate throughout the pharmaceutical industry. Aft . . .